IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q1 2024 Holdings

Filed 2024-04-12 | 5 holdings | $180.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics, Inc.(KYTX)Common Stock501976104$112.4M4,523,92462.4%
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$44.4M3,931,81824.7%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$11.6M407,4996.4%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$8.0M1,798,1634.5%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$3.6M2,765,3142.0%